Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2114447 | Cancer Letters | 2009 | 7 Pages |
Abstract
The analysis of a small number of patients with atypical chronic myeloid leukemia showing balanced chromosomal translocations has revealed diverse tyrosine kinase fusion genes, most commonly involving FGFR1, PDGFRA, PDGFRB, JAK2, and ABL. We present a case of aCML with a 3q22;21q22-translocation that led to truncation of the receptor-like tyrosine kinase (RYK) gene and its juxtaposition with sequences from chromosome 21 including the ATP5O gene coding for a mitochondrial ATP synthase. The resulting fusion was not in frame, however, which is why we speculate that an abrogated RYK gene product rather than a chimeric protein might be the leukemogenic result.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Francesca Micci, Ioannis Panagopoulos, Lisbeth Haugom, Hege Kilen Andersen, Geir E. Tjønnfjord, Klaus Beiske, Sverre Heim,